Krsnaa Diagnostics Limited (KRSNAA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.056x

Based on the latest financial reports, Krsnaa Diagnostics Limited (KRSNAA) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs518.74 Million ≈ $5.61 Million USD) by net assets (Rs9.23 Billion ≈ $99.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Krsnaa Diagnostics Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Krsnaa Diagnostics Limited - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Krsnaa Diagnostics Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Krsnaa Diagnostics Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Krsnaa Diagnostics Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Oceanhawk Acquisition Corp. Class A Ordinary Shares
NASDAQ:OHAC
N/A
Taliworks Corporation Bhd
KLSE:8524
0.013x
Gelecek Varlik Yonetimi AS
IS:GLCVY
0.092x
Viant Technology Inc
NASDAQ:DSP
0.115x
Platinum Group Metals Ltd
TO:PTM
-0.014x
Ferro S.A.
WAR:FRO
0.129x
Canton Strategic Holdings, Inc.
NASDAQ:CNTN
-0.016x
Fiducian Group Ltd
AU:FID
0.212x

Annual Cash Flow Conversion Efficiency for Krsnaa Diagnostics Limited (2017–2025)

The table below shows the annual cash flow conversion efficiency of Krsnaa Diagnostics Limited from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Krsnaa Diagnostics Limited market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs8.83 Billion
≈ $95.47 Million
Rs873.27 Million
≈ $9.44 Million
0.099x +229.06%
2024-03-31 Rs8.10 Billion
≈ $87.58 Million
Rs243.45 Million
≈ $2.63 Million
0.030x -70.89%
2023-03-31 Rs7.39 Billion
≈ $79.89 Million
Rs763.01 Million
≈ $8.25 Million
0.103x -46.22%
2022-03-31 Rs6.69 Billion
≈ $72.32 Million
Rs1.28 Billion
≈ $13.89 Million
0.192x -56.58%
2021-03-31 Rs2.32 Billion
≈ $25.08 Million
Rs1.03 Billion
≈ $11.09 Million
0.442x +330.44%
2020-03-31 Rs-1.97 Billion
≈ $-21.30 Million
Rs378.09 Million
≈ $4.09 Million
-0.192x +72.02%
2019-03-31 Rs-849.21 Million
≈ $-9.18 Million
Rs582.66 Million
≈ $6.30 Million
-0.686x +52.08%
2018-03-31 Rs-228.96 Million
≈ $-2.48 Million
Rs327.85 Million
≈ $3.55 Million
-1.432x -274.29%
2017-03-31 Rs757.06 Million
≈ $8.19 Million
Rs621.99 Million
≈ $6.73 Million
0.822x --

About Krsnaa Diagnostics Limited

NSE:KRSNAA India Diagnostics & Research
Market Cap
$187.21 Million
Rs17.31 Billion INR
Market Cap Rank
#16900 Global
#882 in India
Share Price
Rs533.65
Change (1 day)
+0.08%
52-Week Range
Rs520.30 - Rs867.05
All Time High
Rs1020.15
About

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, su… Read more